Nuedexta Drug Interactions: What to Avoid and What to Tell Your Doctor

Nuedexta (dextromethorphan / quinidine sulfate) has a complex and clinically important drug interaction profile. Because quinidine is a potent inhibitor of the CYP2D6 enzyme and can also prolong the heart's QT interval, Nuedexta interacts with a wide range of commonly prescribed medications. Many patients with pseudobulbar affect (PBA) have neurological conditions requiring multiple medications — making polypharmacy review essential before starting Nuedexta.

The Two Major Interaction Mechanisms to Understand

Before reviewing specific interactions, it helps to understand why Nuedexta interacts with so many drugs:

CYP2D6 inhibition (via quinidine): Quinidine is a potent inhibitor of CYP2D6, the liver enzyme responsible for metabolizing approximately 25% of all prescription drugs. When quinidine blocks CYP2D6, drugs that rely on this enzyme for clearance accumulate to higher levels, potentially causing toxicity.

QT interval prolongation (via quinidine): Nuedexta causes dose-dependent QTc prolongation. Combining it with other QT-prolonging drugs increases the risk of torsades de pointes — a potentially life-threatening ventricular arrhythmia.

Contraindicated Combinations (Do Not Use Together)

MAOIs (monoamine oxidase inhibitors): Absolutely contraindicated. Combining Nuedexta with an MAOI (phenelzine, tranylcypromine, selegiline, rasagiline) can cause serotonin syndrome — a potentially fatal condition. Do not start Nuedexta within 14 days of stopping an MAOI. Do not start an MAOI within 14 days of stopping Nuedexta.

Other quinidine-containing products: Do not take Nuedexta with other medications containing quinidine, quinine, or mefloquine. This includes antimalarials and any cardiac medications containing these compounds.

Thioridazine and pimozide: Contraindicated. Both prolong the QT interval AND are metabolized by CYP2D6, creating a dual risk of QT prolongation and drug accumulation.

Major Interactions Requiring Dose Adjustment or Close Monitoring

SSRIs (especially paroxetine, fluoxetine): Quinidine inhibits CYP2D6-mediated SSRI metabolism, increasing SSRI blood levels. Additionally, both dextromethorphan and SSRIs have serotonergic activity — the combination increases risk of serotonin syndrome. If Nuedexta is prescribed with paroxetine, limit paroxetine to a maximum of 35 mg/day. Monitor for serotonin syndrome symptoms.

Tricyclic antidepressants (TCAs) — especially desipramine: CYP2D6 inhibition by quinidine can increase desipramine plasma levels by approximately 8-fold. If Nuedexta and desipramine must be co-prescribed, use a markedly reduced desipramine dose and limit to a maximum of 40 mg/day. Consider a different antidepressant if possible.

Digoxin: Quinidine inhibits P-glycoprotein, the transporter that eliminates digoxin. Co-administration can double digoxin plasma levels, increasing toxicity risk. If these must be co-prescribed, reduce the digoxin dose and monitor plasma digoxin concentrations closely.

Beta-blockers and antiarrhythmics metabolized by CYP2D6: Metoprolol, carvedilol, propafenone, and flecainide are all CYP2D6 substrates. Quinidine inhibition can increase their plasma levels significantly. Dose adjustments and cardiac monitoring may be needed.

Antipsychotics (haloperidol, risperidone): Many antipsychotics are CYP2D6 substrates and also prolong the QT interval. Co-administration with Nuedexta increases both drug levels and QT risk. Avoid or monitor closely.

Opioids metabolized by CYP2D6 (codeine, tramadol): Quinidine inhibits conversion of codeine to its active form (morphine) and tramadol to its active metabolite. Pain control may be reduced. Discuss with your prescriber if you use opioids for pain.

Moderate Interactions to Be Aware Of

Alcohol and CNS depressants: Additive CNS depression (sedation, dizziness). Avoid alcohol while taking Nuedexta. Be cautious with benzodiazepines, sleeping medications, and antihistamines.

Other dextromethorphan-containing products: Many over-the-counter cough and cold medications contain dextromethorphan (look for "DM" on the label). Taking these while on Nuedexta can result in excessive dextromethorphan levels and increased risk of serotonin syndrome.

Memantine: Another NMDA receptor antagonist used in Alzheimer's. Because both dextromethorphan and memantine act on NMDA receptors, there is a theoretical concern about additive effects. Monitor patients on this combination.

What to Tell Your Doctor and Pharmacist Before Starting Nuedexta

Before starting Nuedexta, provide your prescriber and pharmacist with a complete list of:

All prescription medications, including antidepressants, antipsychotics, cardiac drugs, and pain medications

Over-the-counter medications, especially cough and cold products containing DM

Herbal supplements (especially St. John's Wort, which affects CYP enzymes and serotonin)

Your cardiac history (QT prolongation, arrhythmia, heart failure)

Any prior reactions to quinine or mefloquine (antimalarial drugs structurally related to quinidine)

For a complete overview of Nuedexta's safety profile, see our article on Nuedexta side effects. For general Nuedexta information, visit what is Nuedexta.